Fred Guengerich

The lab of Professor of Biochemistry Fred Guengerich has proposed a paradigm shift in the understanding of a critical chemical reaction involved in sterol biosynthesis. Read More

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer. Read More

Vanderbilt investigators have discovered how mammals, including humans, produce the painkiller morphine. Read More

Vanderbilt University’s F. Peter (Fred) Guengerich, Ph.D., has been named interim editor-in-chief of the Journal of Biological Chemistry (JBC). Read More

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities. Read More

(Photo by Susan Urmy) Jennifer Noto, Ph.D., postdoctoral fellow in the lab of Richard Peek, M.D., receives the 2013 Postdoc of the Year award from Ann Price, M.D., associate dean for Alumni Affairs, during the 7th annual Postdoctoral Research and Shared Resources Symposium on… Read More

F. Peter (Fred) Guengerich, Ph.D., Stanford Moore Professor of Biochemistry, is the 2013 recipient of the Society of Toxicology Merit Award in recognition of distinguished achievements to toxicology throughout his career. Read More